Furthermore, the GSC-derived exosomal miR-944 dramatically limits glioma angiogenesis by targeting the 3’UTR of VEGFC, reducing VEGFC expression, and blocking the AKT/ERK signaling. The gene discussed is VEGFC; the disease is central nervous system cancer.